Code
|
8106A
|
MA number
|
EU/1/02/203/005
|
Product Form:
|
sol inj 1x0,67 ml /100 mg (striek.inj.napl.skl.)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Swedish Orphan Biovitrum AB (publ), Sweden
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
ATC:
|
L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
L04 |
Immunosuppressants |
L04A |
Immunosuppressants |
L04AC |
Interleukin inhibitors |
L04AC03 |
Anakinra |
|
Shelf life:
|
36 |
Container:
|
pre-filled syringe
|
Route of admin.:
|
Subcutaneous use
|